Filed: 11/14/2023ACC: 0001315863-23-000887
📋 What this filing means
TWO SEAS CAPITAL LP filed this quarterly 13F‑HR report disclosing 13 equity positions with a total reported market value of $497.34M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
13
Positions
$497.34M
Total AUM (reported)
57.65M
Total Shares
Allocation by class
ORD$315.37M63.4%
SHS$92.45M18.6%
COM$62.35M12.5%
CL A$10.86M2.2%
NOTE 4.000%11/1$9.36M1.9%
COM NEW$6.20M1.2%
*W EXP 06/30/205$755.8K0.2%
Portfolio Concentration
Top 3$427.55M86.0%
4–10$67.09M13.5%
11–25$2.70M0.5%
Top 3 weight
86.0%
Top 10 weight
99.5%
Voting Authority Distribution
Total shares with voting rights: 57.65M
Sole
Full voting authority
57.65M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole13
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings13
Rows:
INDIVIOR PLC
SOLEShares13.67M
TypeSH
Market value$315.37M
63.41%
Sole
13.67M
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares7.92M
TypeSH
Market value$92.45M
18.59%
Sole
7.92M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares513.86K
TypeSH
Market value$19.73M
3.97%
Sole
513.86K
Shared
0.00
None
0.00
ARBUTUS BIOPHARMA CORP
SOLEShares8.28M
TypeSH
Market value$16.81M
3.38%
Sole
8.28M
Shared
0.00
None
0.00
3M CO
SOLEShares130K
TypeSH
Market value$12.17M
2.45%
Sole
130K
Shared
0.00
None
0.00
META PLATFORMS INC
SOLEShares36.17K
TypeSH
Market value$10.86M
2.18%
Sole
36.17K
Shared
0.00
None
0.00
ESPERION THERAPEUTICS INC NE
SOLEShares17.27M
TypePRN
Market value$9.36M
1.88%
Sole
17.27M
Shared
0.00
None
0.00
ESPERION THERAPEUTICS INC NE
SOLEShares7.67M
TypeSH
Market value$7.52M
1.51%
Sole
7.67M
Shared
0.00
None
0.00
SONOS INC
SOLEShares406.17K
TypeSH
Market value$5.24M
1.05%
Sole
406.17K
Shared
0.00
None
0.00
ODYSSEY MARINE EXPL INC
SOLEShares1.37M
TypeSH
Market value$5.13M
1.03%
Sole
1.37M
Shared
0.00
None
0.00
HERTZ GLOBAL HLDGS INC
SOLEShares87.19K
TypeSH
Market value$1.07M
0.21%
Sole
87.19K
Shared
0.00
None
0.00
ARCUTIS BIOTHERAPEUTICS INC
SOLEShares164.81K
TypeSH
Market value$875.1K
0.18%
Sole
164.81K
Shared
0.00
None
0.00
HERTZ GLOBAL HLDGS INC
SOLEShares123.49K
TypeSH
Market value$755.8K
0.15%
Sole
123.49K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
INDIVIOR PLCSOLE | ORD | 13.67M | SH | $315.37M 63.41% | 13.67M | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 7.92M | SH | $92.45M 18.59% | 7.92M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 513.86K | SH | $19.73M 3.97% | 513.86K | 0.00 | 0.00 |
ARBUTUS BIOPHARMA CORPSOLE | COM | 8.28M | SH | $16.81M 3.38% | 8.28M | 0.00 | 0.00 |
3M COSOLE | COM | 130K | SH | $12.17M 2.45% | 130K | 0.00 | 0.00 |
META PLATFORMS INCSOLE | CL A | 36.17K | SH | $10.86M 2.18% | 36.17K | 0.00 | 0.00 |
ESPERION THERAPEUTICS INC NESOLE | NOTE 4.000%11/1 | 17.27M | PRN | $9.36M 1.88% | 17.27M | 0.00 | 0.00 |
ESPERION THERAPEUTICS INC NESOLE | COM | 7.67M | SH | $7.52M 1.51% | 7.67M | 0.00 | 0.00 |
SONOS INCSOLE | COM | 406.17K | SH | $5.24M 1.05% | 406.17K | 0.00 | 0.00 |
ODYSSEY MARINE EXPL INCSOLE | COM NEW | 1.37M | SH | $5.13M 1.03% | 1.37M | 0.00 | 0.00 |
HERTZ GLOBAL HLDGS INCSOLE | COM NEW | 87.19K | SH | $1.07M 0.21% | 87.19K | 0.00 | 0.00 |
ARCUTIS BIOTHERAPEUTICS INCSOLE | COM | 164.81K | SH | $875.1K 0.18% | 164.81K | 0.00 | 0.00 |
HERTZ GLOBAL HLDGS INCSOLE | *W EXP 06/30/205 | 123.49K | SH | $755.8K 0.15% | 123.49K | 0.00 | 0.00 |